These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 24289637)
1. Association between p53 Arg72Pro polymorphism and the risk of human papillomavirus-related head and neck squamous cell carcinoma: a meta-analysis. Xia LY; Zeng XT; Li C; Leng WD; Fan MW Asian Pac J Cancer Prev; 2013; 14(10):6127-30. PubMed ID: 24289637 [TBL] [Abstract][Full Text] [Related]
2. P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility. Hou J; Gu Y; Hou W; Wu S; Lou Y; Yang W; Zhu L; Hu Y; Sun M; Xue H BMC Genet; 2015 Jun; 16():72. PubMed ID: 26123760 [TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of associations between the TP53 Arg72Pro polymorphism with risk of head and neck carcinomas based on case-control studies. Ren WH; Jiang DK; Pei Y; Wang SQ; Yang XM; Yu L Genet Mol Res; 2014 Jan; 13(1):103-14. PubMed ID: 24446292 [TBL] [Abstract][Full Text] [Related]
4. Association of p53 and MDM2 polymorphisms with risk of human papillomavirus (HPV)-related esophageal squamous cell carcinoma (ESCC). Yang J; Liu B; Li W; Xiong H; Qiu H; Fu Q; Chen B; Hu G; Yuan X Cancer Epidemiol; 2013 Oct; 37(5):629-33. PubMed ID: 23837945 [TBL] [Abstract][Full Text] [Related]
5. p53 Arg72Pro polymorphism confers the susceptibility to endometriosis among Asian and Caucasian populations. Lao X; Chen Z; Qin A Arch Gynecol Obstet; 2016 May; 293(5):1023-31. PubMed ID: 26493553 [TBL] [Abstract][Full Text] [Related]
6. p53 Arg72Pro polymorphism, HPV status and initiation, progression, and development of cervical cancer: a systematic review and meta-analysis. Habbous S; Pang V; Eng L; Xu W; Kurtz G; Liu FF; Mackay H; Amir E; Liu G Clin Cancer Res; 2012 Dec; 18(23):6407-15. PubMed ID: 23065429 [TBL] [Abstract][Full Text] [Related]
7. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis. Jiang DK; Yao L; Wang WZ; Peng B; Ren WH; Yang XM; Yu L World J Gastroenterol; 2011 Mar; 17(9):1227-33. PubMed ID: 21448430 [TBL] [Abstract][Full Text] [Related]
8. Meta-analysis demonstrates association between Arg72Pro polymorphism in the P53 gene and susceptibility to keloids in the Chinese population. Wu Y; Wang B; Li YH; Xu XG; Luo YJ; Chen JZ; Wei HC; Gao XH; Chen HD Genet Mol Res; 2012 Jun; 11(2):1701-11. PubMed ID: 22843046 [TBL] [Abstract][Full Text] [Related]
9. Association between p53 Arg72Pro polymorphism and thyroid cancer risk: a meta-analysis. Wu B; Guo D; Guo Y Tumour Biol; 2014 Jan; 35(1):561-5. PubMed ID: 24037912 [TBL] [Abstract][Full Text] [Related]
10. Fuzzy clustering demonstrates that codon 72 SNP rs1042522 of TP53 gene associated with HNSCC but not with prognoses. Pinheiro UB; Fraga CA; Mendes DC; Farias LC; Cardoso CM; Silveira CM; D'Angelo MF; Jones KM; Santos SH; de Paula AM; GuimarĂ£es AL Tumour Biol; 2015 Dec; 36(12):9259-65. PubMed ID: 26099726 [TBL] [Abstract][Full Text] [Related]
11. TP53 Arg72Pro polymorphism and skin cancer risk: a meta-analysis. Jiang DK; Wang WZ; Ren WH; Yao L; Peng B; Yu L J Invest Dermatol; 2011 Jan; 131(1):220-8. PubMed ID: 20861852 [TBL] [Abstract][Full Text] [Related]
12. p53 Codon 72 polymorphism in oral exfoliated cells in a Sudanese population. Sand L; Jalouli MM; Jalouli J; Sapkota D; Ibrahim SO In Vivo; 2012; 26(1):59-62. PubMed ID: 22210716 [TBL] [Abstract][Full Text] [Related]
13. p53 codon 72 polymorphism and hematological cancer risk: an update meta-analysis. Weng Y; Lu L; Yuan G; Guo J; Zhang Z; Xie X; Chen G; Zhang J PLoS One; 2012; 7(9):e45820. PubMed ID: 23029260 [TBL] [Abstract][Full Text] [Related]
14. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers. Ji X; Neumann AS; Sturgis EM; Adler-Storthz K; Dahlstrom KR; Schiller JT; Wei Q; Li G Carcinogenesis; 2008 Apr; 29(4):875-9. PubMed ID: 18258602 [TBL] [Abstract][Full Text] [Related]
15. Associations of TP53 mutations, codon 72 polymorphism and human papillomavirus in head and neck squamous cell carcinoma patients. Shi Q; Xiao K; Wei W; Zhang BY; Chen C; Xu Y; Chen LN; Song YT; Ma X; Zhang NS; Dong XP Oncol Rep; 2013 Dec; 30(6):2811-9. PubMed ID: 24064928 [TBL] [Abstract][Full Text] [Related]
16. TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis. Jiang DK; Yao L; Ren WH; Wang WZ; Peng B; Yu L Med Oncol; 2011 Dec; 28(4):1129-35. PubMed ID: 20552298 [TBL] [Abstract][Full Text] [Related]
17. Combined effects of leukocyte telomere length, p53 polymorphism and human papillomavirus infection on esophageal squamous cell carcinoma in a Han Chinese population. Yu Q; Yang J; Liu B; Li W; Hu G; Qiu H; Huang L; Xiong H; Yuan X Cancer Epidemiol; 2014 Oct; 38(5):569-75. PubMed ID: 25153662 [TBL] [Abstract][Full Text] [Related]
18. Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk. Lv L; Wang P; Zhou X; Sun B Tumour Biol; 2013 Jun; 34(3):1451-9. PubMed ID: 23564481 [TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma. Zhang F; Li D; Li Y; Li H; Sun J; Li X; Li X Tumour Biol; 2014 Jan; 35(1):747-51. PubMed ID: 24046089 [TBL] [Abstract][Full Text] [Related]
20. [Correlation of 53BP1 and p53 polymorphisms to susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma]. Cao YY; Ge H; Chen LQ; Chen ZF; Wen DG; Li Y; Zhang JH Ai Zheng; 2007 Oct; 26(10):1052-7. PubMed ID: 17927872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]